fig7

An activated CD8<sup>+</sup> T cell-based signature stratifies prognosis and suggests differential sensitivity to immune checkpoint inhibitors in hepatocellular carcinoma

Figure 7. Subgroup analyses confirm stable predictive performance of the risk model across clinical strata. Kaplan-Meier survival analysis showed that the predictive ability of the risk model was stable under clinical characteristics such as M0, N0, T1, T2-4, male, female, and stage I-II. OS: Overall survival.

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/